This system works by storing health data in an AI-assisted digital health registry. However, unlike centralized databases, the Immunity.Life platform lives on the Ethereum blockchain. This decentralized network is the foundation of Immunity.Life, offering transparent, secure access to consistent and interoperable data.
The cost-free platform integrates the needs of patients and professionals by capturing, storing, and transferring health-related data using computers or mobile devices. This accessibility enables remote medical supervision and real-time access to the vital data patients and professionals need. Through the use of its native token (IMM), Immunify.Life will create a transformative, self-sustaining ecosystem that incentivizes sustainable scalability.
This ecosystem will empower all patients across emerging economies and beyond. As an all-in-one platform, Immunify.Life aims to introduce a new health management landscape that can positively influence health behaviours and directly sponsor specific health outcomes. By leveraging AI and blockchain technology to harness Big Data, Immunify.Life enables countless collaborations. These initiatives might include governments, health ministries, subsidiary entities, non-governmental organisations, partner health organisations, for-profit partners, sponsors, or donors.
Today, Immunify.Life is already taking part in such strategic partnerships, such as those with the Masinde Muliro University of Science and Technology (MMUST), and State of the Heart Recovery Centre (SHRC).
Immunify.Life & Masinde Muliro University of Science and Technology (MMUST)
With approval from the Institutional Ethics Committee and National Commission for Science, Technology & Innovation (NACOSTI), Masinde Muliro University of Science and Technology (MMUST), and Immunify.Life have entered into a 5-year collaboration agreement. Working together in Kenya, the two will undertake clinical research to improve patient outcomes and strengthen public health performance. Their first major project will explore incentive effectiveness and paperless tracking for HIV treatment adherence and outcomes in Kenya’s low socio-economic communities.
With around 1.5 million Kenyans living with HIV and the adult (15-49) prevalence rate at 4.5%, the initiative aims to better understand the 42,000 new infections that occur each year. The Immunify.Life platform will serve as a framework for capturing large amounts of vital data for these underserved populations through its streamlined application.
This groundbreaking study will contribute to the future Strategic Direction on HIV in Kenya, improving health outcomes for all people living with HIV. Alongside MMUST, Immunify.Heath will deploy referral tracking mechanisms, improved access to distributed human resource services, increased advocacy on anti retro treatment (ART) uptake, and adherence to interventions that improve quality of care and outcomes.
Immunify.Life & State of the Heart Recovery Centre (SHRC)
Immunify.Life has also entered into a partnership with the State of the Heart Recover Centre (SHRC) from Albuquerque, New Mexico. According to the World Health Organization (WHO), around 500,000 people die each year from medical and illicit drug use. More than 70% of these deaths are related to opioid use, with more than 30% of those deaths caused by overdose. To better understand these figures, SHRC and Immunify.Life will apply data and technological solutions to addiction recovery and treatment. With a particular focus on opioid addiction, the partnership will explore the opportunities and challenges of substance abuse.
SHRC is an all-inclusive treatment center for substance abuse, including opioid addiction. While SHRC is an accredited treatment facility for opioid addiction, it adheres to a more holistic addiction recovery regimen, emphasizing emotional, spiritual, and physical well-being. To deliver this program, the facility integrates traditional evidence-based treatments and mobile devices equipped with biometric feedback.
As a mobile-native solution, the Immunify.Life platform integrates seamlessly with this existing programming. As such, the proprietary Immunity.Life app will record, track, and analyze clinical outcomes and behaviour modifications related to treatment adherence. The collaboration will also integrate the IMM token to incentivize patients to adhere to treatment. A clinical pilot of Immunify technology in this therapeutic setting is expected to commence in Q4, 2021.
Continue reading on CoinQuora
Source: Cryptocurrency - investing.com
